Mr Taylor’s study into the benefits of Fractional CO₂ laser monotherapy for treating Genitourinary syndrome of menopause (GSM) has been published in Maturitas – The International Journal of Midlife Health.
Described as a “gamechanging” drug by The Guardian and others, Veoza (or Veozah in the USA) prevents hot flushes and could benefit hundreds of thousands of women. And it has now been approved for use in the UK.